H7N9 patients show signs of resistance to oseltamivir

05/29/2013 | DoctorsLounge.com

A report in The Lancet said viral samples from three of 14 patients treated for H7N9 in a hospital in Shanghai appear to be resistant to oseltamivir. The three had mutations observed in other instances of oseltamivir resistance. The mutation may have developed in one patient after treatment with the drug, indicating that H7N9 may easily adapt, researchers said.

View Full Article in:

DoctorsLounge.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX